An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer

Journal of the National Cancer Institute

Volumn 94, Issue 14, 2002, Pages 1091-1099

  Bosken, Carol H ^a   Wei, Qingyi ^a   Amos, Christopher I ^a   Spitz, Margaret R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DNA; DOCETAXEL; GEMCITABINE; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; TOPOTECAN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CASE CONTROL STUDY; CELL ASSAY; CONTROLLED STUDY; DNA REPAIR; EXCISION REPAIR; FEMALE; FOLLOW UP; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RANK SUM TEST; RISK ASSESSMENT; RISK FACTOR; STATISTICAL DISTRIBUTION; WEIGHT REDUCTION;

EID: 0037125382     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.14.1091     Document Type: Article

References (44)

1. Cancer statistics, 2002
2. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
3. Clinical perspectives on platinum resistance
4. Molecular mechanisms involved in cisplatin cytotoxicity
5. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy
6. DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy
7. Reduced DNA repair capacity in lung cancer patients
8. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy
9. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy
10. Nucleotide excision repair and human syndromes
11. Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells
12. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy
13. Expression of ERCC1 antisense RNA abrogates gemcitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair
14. Mechanisms of resistance to cisplatin
15. An ERCC1 splicing variant involving the 5′UTP of the mRNA may have a transcriptional modulatory function
16. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study
17. Revisions in the International System for Staging Lung Cancer
18. Comparison of National Death Index and World Wide Web death searches
19. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes
20. Inactivation of plasmid reporter gene expression by one benzo(a)pyrene diol-epoxide DNA adduct in adult rat hepatocytes
21. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients
22. A simple and rapid method for evaluating the survival of xeroderma pigmentosum lymphoid lines after irradiation with ultraviolet light
23. Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethyl-aminoethyl-dextran
24. Fluorescence in situ hybridization method for measuring transfection efficiency
25. Survival analysis: Techniques for censored and truncated data
26. Adaptive enhancement and kinetics of nucleotide excision repair in humans
27. Paclitaxcel, cisplatin, and cyclophosphamide in human ovarian cancer: Molecular rationale and early clinical results
28. DNA repair capacity in healthy medical students during and after exam stress
29. Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells
30. Proteins that specifically recognize cisplatin-damaged DNA: A clue to anticancer activity of cisplatin
31. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts
32. Physical interaction between components of DNA mismatch repair and nucleotide excision repair
33. DNA repair and mutagenesis
34. The response of cellular proteins to cisplatin-damaged DNA
35. Difference and similarities in the repair of two benzo[a]pyrene diol epoxide isomers induced DNA adducts by uvrA, uvrB, and uvrC gene products
36. Prognostic factors for survival in advanced non-small-cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients
37. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience
38. Modulation of cisplatin resistance in acquired-resistant non small cell lung cancer cells
39. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
40. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells
41. Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines
42. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients
43. Correlation of gene-specific damage with cisplatin between human adenocarcinoma cells and peripheral blood mononuclear cells analyzed by polymerase chain reaction-stop assay